Breakthrough Glaucoma Surgical Technologies

Iantrek is developing and commercializing next-generation technologies to assist patients with glaucoma. Through its portfolio of bio¬-interventional tools Iantrek is deploying tissue-based solutions to enhance ocular outflow when pharmaceutical therapy is no longer effective. It’s lead product, AlloFlo, uses scleral tissue to support the uveoscleral pathway and promote enhanced ocular drainage.